Current and future use of angiotensin II receptor blockers in patients with COVID-19
No scientific evidence for the negative influence of angiotensin II receptor blockers onto COVID-19 clinical course has been identified so far. Prescribing angiotensin II receptor blockers as COVID-19 pathogenetic therapy could only be considered within clinical trials. Patients who have been taking...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Izdatelstvo OKI
2020-10-01
|
| Series: | Качественная клиническая практика |
| Assuntos: | |
| Acceso en liña: | https://www.clinvest.ru/jour/article/view/521 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|